Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2025 00:27 ET | Source: Sapu Bioscience, LLC

Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

San Diego, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sapu Nano, a clinical-stage nanomedicine company, today announced new data demonstrating that its proprietary Deciparticle™ platform enables...
December 02, 2025 08:00 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

AGOURA HILLS, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano, a clinical-stage nanomedicine company, today announced new data...
November 26, 2025 07:14 ET | Source: Research and Markets

Antibiotic Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 137 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
September 04, 2025 07:07 ET | Source: Research and Markets

Guanine for Pharmaceuticals | 2025-2030 Market Analysis | Precision Medicine Advancements Drive Business Opportunities

Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Guanine for Pharmaceuticals Market by Antibiotics (Beta Lactams, Macrolides, Tetracyclines), Anticancer Agents (Alkylating Agents, Platinums) - Global...
June 17, 2025 07:37 ET | Source: Research and Markets

Antibiotic Collaboration and Licensing Agreements Analysis Report and Directory 2016-2025: Benchmark Deals Entered Into by the World's Leading Biopharma Companies

Dublin, June 17, 2025 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering.This report contains a...
January 31, 2025 09:22 ET | Source: Research and Markets

Antibiotic Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 133 Agreements Signed by the World's Leading Biopharma Companies

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and...
December 26, 2024 04:45 ET | Source: Research and Markets

Antibiotic Resistance Therapeutics Market Research Report 2025-2029 - Search for Alternatives to Antibiotics Creates New Global Goldrush

Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides"...
October 15, 2024 10:31 ET | Source: Research and Markets

Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
May 27, 2024 03:01 ET | Source: Research and Markets

Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush

Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
May 07, 2024 06:41 ET | Source: Research and Markets

Antibiotic Collaboration and Licensing Deals Analysis Report 2024 with Directory of 133 Agreements Signed Since 2019

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and...